What is she best known for?
The fields of study Maryla Krajewska is best known for:
Maryla Krajewska frequently studies issues relating to Tyrosine kinase and Cell biology.
She performs integrative Tyrosine kinase and Signal transduction research in her work.
Maryla Krajewska connects Signal transduction with Death domain in her study.
In her works, Maryla Krajewska undertakes multidisciplinary study on Death domain and Caspase.
She regularly links together related areas like Inhibitor of apoptosis domain in her Caspase studies.
Maryla Krajewska combines Programmed cell death and Cell growth in her research.
Maryla Krajewska integrates Cell growth and Programmed cell death in her research.
Maryla Krajewska applies her multidisciplinary studies on Apoptosis and TUNEL assay in her research.
In her works, Maryla Krajewska performs multidisciplinary study on TUNEL assay and Apoptosis.
Her most cited work include:
- Prognostic Significance of Bcl-2 Protein Expression and Bcl-2 Gene Rearrangement in Diffuse Aggressive Non-Hodgkin's Lymphoma (477 citations)
- Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial (472 citations)
- Upregulation of bax protein levels in neurons following cerebral ischemia (413 citations)
What are the main themes of her work throughout her whole career to date
Her work often combines Biochemistry and Neuroscience studies.
She integrates Neuroscience with Biochemistry in her research.
In her research, she undertakes multidisciplinary study on Apoptosis and Caspase.
Maryla Krajewska integrates many fields in her works, including Caspase and Programmed cell death.
Programmed cell death and Caspase 3 are frequently intertwined in her study.
Maryla Krajewska merges Caspase 3 with Apoptosis in her study.
Maryla Krajewska combines Cancer research and Prostate cancer in her studies.
In her work, she performs multidisciplinary research in Prostate cancer and Cancer research.
Her study on Genetics is mostly dedicated to connecting different topics, such as Cell culture.
Maryla Krajewska most often published in these fields:
- Biochemistry (57.14%)
- Apoptosis (53.97%)
- Cancer research (49.21%)
What were the highlights of her more recent work (between 2011-2014)?
- Cell biology (66.67%)
- Cancer research (66.67%)
- Genetics (66.67%)
In recent works Maryla Krajewska was focusing on the following fields of study:
The study of Cell biology is intertwined with the study of Stem cell in a number of ways.
While working on this project, she studies both Stem cell and Bone marrow.
She connects Bone marrow with Progenitor cell in her research.
Many of her studies involve connections with topics such as Cell biology and Progenitor cell.
In her articles, Maryla Krajewska combines various disciplines, including Cancer research and Oncology.
Maryla Krajewska performs multidisciplinary studies into Oncology and Pathology in her work.
Pathology is closely attributed to Soft tissue in her study.
She incorporates Soft tissue and Cancer in her studies.
Her study deals with a combination of Cancer and Cell culture.
Between 2011 and 2014, her most popular works were:
- A Pan-BCL2 Inhibitor Renders Bone-Marrow-Resident Human Leukemia Stem Cells Sensitive to Tyrosine Kinase Inhibition (156 citations)
- Endoplasmic reticulum protein BI-1 regulates Ca2+-mediated bioenergetics to promote autophagy (82 citations)
- Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation (77 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
